"/>

Biogen and Elan report Tysabri brain disease cases

July 31, 2008 on 7:15 pm | In Business News |

LOS ANGELES/NEW YORK (Reuters) - Biogen Idec and Elan have notified regulators of two new cases of a potentially deadly brain disease in multiple sclerosis (MS) patients being treated with Tysabri.

See original here:
Biogen and Elan report Tysabri brain disease cases

No Comments yet

TrackBack URI

Sorry, the comment form is closed at this time.

Entries and comments feeds. Valid XHTML and CSS

Copyright Galaxy Visions Group